Table 2

Annual medical expenditure (2020 US$) and average HbA1c values before and after the diagnosis of type 2 diabetes estimated from the panel linear regression with fixed effects

Total medical expenditure, 2020 US$
(n=83 526)
Average HbA1c, mmol/mol
(n=34 533)
VariableCoefficientSEP valueCoefficientSEP value
Time
−10−$8644$674<0.0001−12.181.17<0.0001
−9−$8509$584<0.0001−7.640.98<0.0001
−8−$8461$524<0.0001−8.510.65<0.0001
−7−$7745$483<0.0001−7.740.49<0.0001
−6−$8027$449<0.0001−7.060.36<0.0001
−5−$7027$421<0.0001−6.630.29<0.0001
−4−$7061$396<0.0001−6.130.23<0.0001
−3−$6696$372<0.0001−5.730.18<0.0001
−2−$6419$350<0.0001−4.880.15<0.0001
−1−$5781$348<0.0001−3.490.13<0.0001
0
1−$3160$345<0.0001−2.000.12<0.0001
2−$2491$374<0.0001−1.610.14<0.0001
High cost
Cancer$9146$346<0.0001−0.150.160.3781
HIV/AIDS$6257$34180.0672−0.661.600.6803
Childbirth$15 797$1147<0.0001−2.780.64<0.0001
Comorbidities
Hypertension$6065$276<0.0001−0.140.150.3408
Hyperlipidemia$579$2440.0179−0.110.130.4095
Chronic obstructive pulmonary disease$6834$535<0.0001−0.200.270.4705
Dementia$33 724$1813<0.0001−1.230.840.1429
Paralysis$55 342$2286<0.0001−0.361.050.7342
Liver disease$4106$335<0.0001−0.140.160.3909
Ulcers$14 085$939<0.0001−0.340.370.3586
Rheumatoid disease$11 105$934<0.0001−0.630.420.1373
Unadjusted mean outcome during index year$17 61547.1 mmol/mol
  • Coefficients in the total medical expenditure regression are in 2020 dollars. Coefficients in average HbA1c regression are in mmol/mol. The HbA1c sample includes person-years where an individual has at least one HbA1c test value during the year and is a subsample of the total medical expenditure sample.